NCT00414336View on ClinicalTrials.gov

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 15, 2006

Primary Completion Date

December 15, 2006

Study Completion Date

December 15, 2006

Conditions
Malaria
Interventions
DRUG

AMA1-C1/Alhydrogel + CPG 7909 Vaccine

Trial Locations (1)

Unknown

Doneguebougou Malaria Vaccine Center, Donéguébougou

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases@@@Coley Pharmaceutical Group

UNKNOWN

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00414336 - Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria | Biotech Hunter | Biotech Hunter